Tranilast/allopurinol - Nuon Therapeutics
Alternative Names: NU-1618Latest Information Update: 12 Aug 2015
At a glance
- Originator Nuon Therapeutics
- Class Anthranilic acids; Antigouts; Antirheumatics; Purines; Small molecules; Uricosurics
- Mechanism of Action Immunomodulators; SLC2A9 protein inhibitors; Xanthine oxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gout; Hyperuricaemia
Most Recent Events
- 05 Jan 2011 Nuon Therapeutics completes the phase II TAnGO trial in Gout in USA (NCT01109121)
- 23 Jun 2010 Efficacy and adverse events data from clinical trials in Hyperuricaemia released by Nuon Therapeutics
- 23 Jun 2010 Pharmacodynamics data from a preclinical trial in Gout released by Nuon Therapeutics